Thymosin Alpha-1: Reference Overview and Reconstitution Notes

Thymosin Alpha-1 is a small peptide (a short chain of protein building blocks) made of 28 amino acids. It is grouped in the immune category. It is approved as a pharmaceutical drug in several countries, but it is not FDA-approved in the United States.

What it is

Thymosin Alpha-1 is a man-made (synthetic) peptide. A peptide is a short chain of amino acids, which are the building blocks the body uses to make proteins. This particular peptide has 28 amino acids linked in a row.

It was first identified as a piece of a larger substance called thymosin fraction 5, which comes from the thymus gland. The thymus is a small organ in the chest that plays a key role in training immune cells. Thymosin Alpha-1 belongs to the thymic peptide family, a group of natural signaling molecules tied to the thymus and to how immune cells grow up and mature.

Research context and categorization

Thymosin Alpha-1 is grouped under the immune category, alongside related thymic peptides such as thymalin and thymulin. It is studied for its connection to immune modulation, which simply means the way the immune system is adjusted or kept in balance.

In lab and clinical research, it has been looked at for its role in helping precursor T-cells develop into mature T-cells. Precursor T-cells are young, unfinished immune cells. Mature T-cells are fully trained and ready to work. Think of it like helping raw recruits complete their training and become active soldiers.

Beyond that, the peptide is studied in several contexts:

• Viral conditions such as hepatitis B and hepatitis C
• Supporting immune function alongside oncology (cancer research) work
• Sepsis (a serious, body-wide response to infection) and immune response to infectious disease
• Anti-aging and general immune resilience

In roughly three dozen countries, the peptide (sold under the brand name Zadaxin) is an approved pharmaceutical drug for some of these uses. In the United States, however, it is not FDA-approved. Any research uses described here are investigational, meaning they are not confirmed or approved outcomes.

Status

• Regulatory status: Research-only in the United States, not FDA-approved. It is approved as a drug in several other countries for specific uses such as hepatitis B and hepatitis C. In the U.S., its compounding status (whether licensed pharmacies may prepare it) has shifted over time as regulations have changed.
• Sport status: Thymosin Alpha-1 is not specifically listed on the WADA Prohibited List (the global list of substances banned in competitive sports). This is different from the related peptide Thymosin Beta-4 (and products such as TB-500), which is banned under the category of growth factors and growth factor modulators. Athletes should always confirm current status with their own governing body, because some substances can fall under the non-approved-substances provision (S0), and the lists are updated regularly.

Reconstitution notes (general)

Thymosin Alpha-1 typically comes as a lyophilized (freeze-dried) powder. Before lab use, it is reconstituted, meaning the powder is mixed with bacteriostatic water (sterile water with a small amount of preservative added) to turn it back into a liquid.

The concentration of the resulting solution is simple to calculate. Divide the milligrams in the vial by the milliliters of water you add. For example, a 5 mg vial mixed with 2.5 mL of water gives you 2 mg/mL. To skip the math, use the calculator at peptide calculator.

Dilution and handling notes (compound-specific)

Common vial sizes are 5 mg and 10 mg. Most lab preparations use roughly 1 mL to 3 mL of water per vial. The amount is chosen mainly for ease of measurement, not because of any chemical requirement.

Typical preparation examples include:

• A 5 mg vial mixed with about 2.5 mL to 3 mL of bacteriostatic water, giving roughly 1.67 mg/mL to 2 mg/mL.
• A 10 mg vial mixed with about 2 mL to 3 mL, giving roughly 3.3 mg/mL to 5 mg/mL.

Handling Best Practices

Thymosin Alpha-1 dissolves easily in water. At the concentrations listed above, it does not usually cloud up, gel, or form clumps. This makes it one of the more cooperative peptides to work with at the bench.

Because it is a somewhat delicate peptide, the main handling tip is about how you add the water. Do not aim the stream of water directly at the powder pellet. Instead, angle it gently down the inner glass wall of the vial and let the water run slowly over the powder. Then let it sit and swirl the vial slowly rather than shaking it.

Shaking forces air into the solution, creates foam, and can cause the peptide to clump (a process called aggregation). If some material is still not dissolved, gentle swirling and a short rest will usually finish the job without any added heat. The reconstituted solution is also sensitive to light, so keep it away from direct light during storage.

Key point: Avoid shaking the vial during reconstitution. Run water gently down the inner glass wall and swirl slowly to prevent foaming and peptide aggregation (clumping).

Handling and storage

Proper storage keeps the reconstituted peptide stable. Follow these standard lab steps:

• Store reconstituted Thymosin Alpha-1 in the refrigerator at 2 to 8 degrees Celsius, kept away from direct light.
• Wipe the rubber stopper with an alcohol swab before drawing from the vial. Label the vial with the date you mixed it so you always know how old the solution is.
• A reconstituted vial is generally considered usable for about four weeks when refrigerated. Some references suggest an even shorter window, so lean toward the more conservative (shorter) side.
• Avoid freeze-thaw cycles (do not freeze the solution and then thaw it repeatedly).
• Discard the solution if it turns cloudy or discolored, or if you see any visible particles floating in it.

Related reading

• Vesugen
• VIP (Vasoactive Intestinal Peptide)
• 5-Amino-1MQ
• How Reconstitution Works
• How Long Does a Reconstituted Vial Last?

Tools and supplies

• peptide calculator
• Bacteriostatic Water 30 ml
• Gansulin Metal Reusable Pen
• 3 ml Glass Cartridges (10-pack)
• Complete Starter Kit

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.

Frequently asked questions

What is Thymosin Alpha-1 and what is it studied for in research?

A synthetic 28-amino-acid thymic peptide first isolated from thymosin fraction 5. Research examines immune modulation and T-cell maturation. Approved as Zadaxin in roughly three dozen countries; not FDA-approved in the United States.

Is Thymosin Alpha-1 banned by WADA or prohibited in competitive sports?

It is not specifically listed on the WADA Prohibited List, unlike Thymosin Beta-4/TB-500. Athletes should confirm current status with their governing body, as the S0 non-approved-substances provision can apply to unlisted compounds.

How do you calculate concentration when reconstituting Thymosin Alpha-1 powder?

Divide the milligrams in the vial by the milliliters of bacteriostatic water added. Example: a 5 mg vial plus 2.5 mL of bacteriostatic water yields a 2 mg/mL solution.

What the research community gets wrong about Thymosin Alpha-1

• It gets confused with Thymosin Beta-4 (TB-500). They sound alike, but they are different peptides with different amino acid sequences. This matters at the bench because it changes which reference sheet and handling notes apply. It also matters for records, since Thymosin Beta-4 is treated very differently on sport banned lists than Thymosin Alpha-1.
• "Not FDA-approved" does not mean "unstudied" or "the same everywhere." In the United States it is a research-only material, but it is an approved pharmaceutical (thymalfasin, brand name Zadaxin) in roughly three dozen other countries. The regulatory label describes legal status in a place, not the size of the research literature.
• Adding more water does not add more peptide. The vial holds a fixed number of milligrams. Water volume only sets the concentration (mg/mL). A common mix-up is picking a volume hoping to get "more" material, when all you are changing is how concentrated each milliliter is.
• "Dissolves easily" is read as "handle it roughly." It does go into solution well, but it is still a delicate peptide. Shaking pushes air into the liquid, makes foam, and can cause the chains to clump together (aggregation). Gentle swirling and a short rest do the same job without that risk.
• A refrigerated vial is not stable forever. The solution is sensitive to light and to repeated freeze and thaw. Treating a reconstituted vial as good for months, or leaving it out on the bench, works against what the storage references actually support.

From our bench: If you have reconstituted a Thymosin Alpha-1 vial, we would like your firsthand observation on how it goes into solution. Note the vial size (mg) and the water volume you added, then record roughly how long the powder took to fully clear after gentle swirling, and whether you saw any foam, haze, or leftover particles. Please send only what you actually measured or saw at your own bench, with no filled-in or estimated numbers.

Sources

1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
4. PubChem: Thymalfasin (Thymosin Alpha-1), CID 16130571 (molecular formula C129H215N33O55)
5. Dominari A, et al. Thymosin alpha 1: A comprehensive review of the literature. World J Virol. 2020;9(5):67-78 (PMID 33362999)
6. King R, Tuthill C. Immune Modulation with Thymosin Alpha 1 Treatment. Vitam Horm. 2016;102:151-78 (PMID 27450734)